Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2016 1
2018 1
2019 2
2020 3
2021 3
2022 1
2023 8
2024 6
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Measurable Residual Disease-Guided Therapy in Newly Diagnosed Myeloma.
Perrot A, Lambert J, Hulin C, Pieragostini A, Karlin L, Arnulf B, Rey P, Garderet L, Macro M, Escoffre-Barbe M, Gay J, Chalopin T, Gounot R, Schiano JM, Mohty M, Leleu X, Manier S, Mariette C, Chaleteix C, Braun T, De Prijck B, Avet-Loiseau H, Mary JY, Corre J, Moreau P, Touzeau C; MIDAS Study Group. Perrot A, et al. N Engl J Med. 2025 Jul 31;393(5):425-437. doi: 10.1056/NEJMoa2505133. Epub 2025 Jun 3. N Engl J Med. 2025. PMID: 40459097 Clinical Trial.
A consensus of European experts on the definition of ventilator-associated pneumonia recurrences obtained by the Delphi method: the RECUVAP study.
Gaillet A, Luyt CE, Timsit JF, Asehnoune K, Barbier F, Bassetti M, Bouadma L, Bouglé A, Chastre J, Morris AC, De Waele JJ, Dépret F, Dimopoulos G, Ehrmann S, Ewig S, Fartoukh M, Foucrier A, Garnacho-Montero J, Hraiech S, Leone M, Makris D, Martin-Loeches I, Matthaiou D, Monsel A, Montravers P, Nseir S, Paiva JA, Papazian L, Poulakou G, Póvoa P, Pugin J, Rodriguez AH, Roquilly A, Roux D, Rouzé A, Taccone FS, Torres A, Zahar JR, Weiss E, Razazi K. Gaillet A, et al. Intensive Care Med. 2025 Mar;51(3):506-517. doi: 10.1007/s00134-025-07856-7. Epub 2025 Mar 31. Intensive Care Med. 2025. PMID: 40163131
Penile Calciphylaxis.
Gaillet A, Luque Y. Gaillet A, et al. Urology. 2020 Jun;140:e8-e9. doi: 10.1016/j.urology.2020.03.003. Epub 2020 Mar 16. Urology. 2020. PMID: 32194088
Clinical Phenotypes and Outcomes Associated With Respiratory Syncytial Virus Infection in Critically Ill Patients: A Retrospective Multicenter Cohort Study in Greater Paris Area Hospitals, 2017-2023.
Gaillet A, Layese R, Fourati S, Celante H, Pham T, Benghanem S, Mekontso Dessap A, de Montmollin E, Pirault J, Vieillard-Baron A, Maury E, Cohen Y, Decavèle M, Fartoukh M, Heming N, Damoisel C, Oubaya N, de Prost N; Prono-RSV study group of the clinical data warehouse of Greater Paris University Hospitals. Gaillet A, et al. J Infect Dis. 2025 Sep 15;232(3):679-690. doi: 10.1093/infdis/jiaf129. J Infect Dis. 2025. PMID: 40073370
Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric study.
Huang F, Khellaf LR, Lefèvre G, Berti A, d'Humières T, Sionis A, Solé AA, Bello F, Bermeo Garrido JA, Crickx E, Delvino P, Emmi G, Gaillet A, Garcia G, Gavand PE, George JL, Gilles F, Golden C, de Groote P, Guffroy A, Martis N, Monti S, Mourlanette P, Pineton de Chambrun M, Prunier F, Regola F, Seret G, Terrier B, Tréfond L, Souteyrand G, Varenne O, Zilio F, Haziza F, Benamer H, Kahn JE, Vallée A, Groh M; French National Reference Center for Hypereosinophilic Syndromes and European EGPA Study Groups. Huang F, et al. Among authors: gaillet a. J Allergy Clin Immunol Pract. 2024 May;12(5):1377-1381.e2. doi: 10.1016/j.jaip.2024.01.036. Epub 2024 Feb 1. J Allergy Clin Immunol Pract. 2024. PMID: 38307204 No abstract available.
ICU mortality of post-myocardial infarction ventricular septal defect complicated by cardiogenic shock: a retrospective multicentric cohort.
Azoulay LD, Bagate F, Delmas C, Paulus S, Mongardon N, Abou-Arab O, Squara P, Habis M, Nougue H, Morichau-Beauchant T, Kimmoun A, Seemann A, Radu C, de Roux Q, Treille de Grandsaigne H, Fellahi JL, Beyls C, Cholley B, Klein T, Gaillet A, Mekontso Dessap A; French PMI-VSD-Shock Study Group (FPSG). Azoulay LD, et al. Among authors: gaillet a. Crit Care. 2025 Mar 18;29(1):119. doi: 10.1186/s13054-025-05321-x. Crit Care. 2025. PMID: 40102946 Free PMC article.
Diagnosing and Managing Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017-2023.
Ingen-Housz-Oro S, Matei I, Gaillet A, Gueudry J, Zaghbib K, Assier H, Wolkenstein P, de Prost N; French National Reference Center for Toxic Bullous Diseases and Severe Drug Reactions (TOXIBUL). Ingen-Housz-Oro S, et al. Among authors: gaillet a. J Invest Dermatol. 2025 Jul;145(7):1589-1603. doi: 10.1016/j.jid.2024.06.1295. Epub 2025 Feb 27. J Invest Dermatol. 2025. PMID: 40019457 Review.
French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens-Johnson syndrome and toxic epidermal necrolysis).
Ingen-Housz-Oro S, Matei I, Gaillet A, Gueudry J, Zaghbib K, Assier H, Hua C, Bensaid B, Colin A, Ouedraogo R, Redlich J, Courtois E, Chazelas K, Sbidian E, Nakad L, Bequignon E, Terkmane N, Gaultier F, Schlemmer F, Do-Pham G, Barbaud A, Lebrun-Vignes B, Hoffmann C, Mahé PJ, Le Floch R, Bernier C, Vabres B, Milpied B, Delcampe A, Tétart F, Tauber M, Staumont-Sallé D, Dezoteux F, Descamps V, Misery L, Bursztejn AC, Dereure O, Amazan E, Le Bidre E, Le Pallec S, Lagier C, Laroche A, Ferrat E, Wolkenstein P, de Prost N; French National Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL. Ingen-Housz-Oro S, et al. Among authors: gaillet a. Ann Dermatol Venereol. 2024 Jun;151(2):103282. doi: 10.1016/j.annder.2024.103282. Epub 2024 May 28. Ann Dermatol Venereol. 2024. PMID: 38810539 Free article. No abstract available.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D; EU SolidAct study group. Trøseid M, et al. Crit Care. 2023 Jan 10;27(1):9. doi: 10.1186/s13054-022-04205-8. Crit Care. 2023. PMID: 36627655 Free PMC article. Clinical Trial.
33 results